Evotec extends Huntington's collaboration
This article was originally published in Scrip
Evotec has extended its collaboration with CHDI Foundation through to the end of 2012. The collaboration, which is aimed at finding new treatments for Huntington's disease, will provide Evotec with up to $37.5 million in research funding over the next three years. Evotec has been providing research and innovation support to CHDI since 2006.